Scurvy

disease
On this page

Also known as ascorbic acid deficiencydeficiency of vitamin Cscorbutusvitamin C deficiencyvitamin C, inability to synthesise

Summary

Scurvy (MONDO:0009412) is a disease and 15 clinical trials. Top therapeutic interventions include cholecalciferol. A subtype of vitamin deficiency disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 15

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namescurvy
Mondo IDMONDO:0009412
EFOEFO:1001169
MeSHD001206, D012614
OMIM240400
DOIDDOID:13577, DOID:13724
ICD-10-CME54
ICD-11708602629
NCITC35010
SNOMED CT76169001
UMLSC0036474
MedGen20684
MedDRA10039768, 10047623
Is cancer (heuristic)no

Also known as: ascorbic acid deficiency · deficiency of vitamin C · scorbutus · scurvy · vitamin C deficiency · vitamin C, inability to synthesise

Disease family

This is a subtype of vitamin deficiency disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › nutritional disordernutritional deficiency diseasevitamin deficiency disorderscurvy

Related subtypes (7): nutritional biotin deficiency, vitamin K deficiency hemorrhagic disease, inborn vitamin metabolic disorder, vitamin A deficiency, vitamin B deficiency, vitamin D deficiency, vitamin deficiency related neuropathy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated for this disease

1 approved. Disease-direct ChEMBL indications, not inferred from the associated-gene cohort below.

DrugDevelopment status
Ascorbic AcidApproved (phase 4)

Clinical trials & evidence

Clinical trials

Clinical trials: 15.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified10
PHASE22
PHASE1/PHASE21
PHASE11
EARLY_PHASE11

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00921622PHASE2COMPLETEDVitamin Deficiency and Blood Pressure in Hospitalized Jewish General Hospital (JGH) Patients
NCT03224572PHASE1/PHASE2UNKNOWNThe Effect of Vitamin C on Quality of Life of Terminal Cancer Patients
NCT05733078PHASE2UNKNOWNEffect of Vitamin C Supplementation in Patients With Primary Hypothyroidism
NCT02606773PHASE1COMPLETEDNovo C Plus Vitamin C Containing Dietary Supplement Bioavailability in Healthy Subjects
NCT05009355EARLY_PHASE1UNKNOWNThe Effect of Vitamin C on GCF Total Oxidant Capacity in Smoker Patients With Periodontitis
NCT06395259Not specifiedACTIVE_NOT_RECRUITINGObservational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation
NCT06876545Not specifiedNOT_YET_RECRUITINGVitamin C Deficiency in Hospitalized Adults: Systematic Screening Vs. Traditional Judgment - a Before-and-After Observational Study
NCT02422901Not specifiedUNKNOWNA Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency
NCT03807791Not specifiedCOMPLETEDStudy of Prevalence and Risk Factors of Hypovitaminosis C in Long Term Care Unit
NCT03913468Not specifiedCOMPLETEDOutcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine.
NCT03938584Not specifiedCOMPLETEDThe Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients
NCT04284696Not specifiedCOMPLETEDChewing Gum Containing Vitamin-c to Treat Emesis Gravidarum
NCT04886752Not specifiedCOMPLETEDThe Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.
NCT05612867Not specifiedCOMPLETEDLow Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
NCT07285109Not specifiedCOMPLETEDThe Impact of Qualia Vitamin C+ on Blood Vitamin C Levels

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
CHOLECALCIFEROL41